Abstract:Detection of small numbers of breast cancer cells is important in staging the disease and can be helpful in assessing the efficacy of purging regimens prior to autologous stem cell infusion. Immunohistochemical methods are potentially useful and broadly applicable for this purpose since they are simple to perform, sensitive, and may be quite specific. We have used a combination of four monoclonal antibodies [260F9, 520C9, 317G5 (Baxter Corp); BrE-3 (Dr. R. Ceriani)] against tumor cell surface glycoproteins in a sensitive immunocytochemical assay to identify breast tumor cells in bone marrow and peripheral blood. Immunostained cytospin preparations were fixed prior to staining to preserve cytological details of immunopositive cells. After immunostaining, slides were counterstained with hematoxylin to confirm the identity of labeled cells. In cytocentrifuge experiments in which small numbers of CAMA human breast tumor cells were added to bone marrow mononuclear cells, a linear relationship between the number of tumor cells added and the number of tumor cells detected was obtained over a broad range of tumor cell concentrations. The probability of detecting tumor cells was dependent on the number of cytocentrifuge slides examined. When ten slides (5 million cells) were examined, the probability of detecting tumor at a concentration of 4 tumor cells per million bone marrow mononuclear cells was 98%. In clinical specimens, tumor cells were detected in marrow aspirates from 73 of 240 (30%) patients undergoing autologous transplantation, including 70 (37%) of 190 patients with clinical stage IV disease, 0 of 7 patients with clinical stage III disease, and 3 of 43 (7%) patients with clinical stage II disease. Seventy-three of 657 peripheral blood specimens from 26 of 155 patients (17%) contained breast cancer cells with counts ranging from 1 to 97 tumor cells per million leukocytes. Tumor cells were most frequently found in the blood of patients with stage IV disease [21 of 107 (20%)] but were also found in a substantial number [5 of 44 (11%)] of patients with stage II disease. Positive selection of CD34-positive hematopoietic progenitor cells as well as negative purging methods such as incubation with 4-hydroxyperoxy-cyclophosphamide (4-HC) were evaluated with respect to tumor cell depletion. Selection of CD34-positive progenitor cells from bone marrow or peripheral blood resulted in log reduction of 1 to > 4 tumor cells reinfused at autologous transplantation. A lesser log reduction (up to 1) was demonstrated following 4-HC purging. We conclude that properly performed and controlled immunocytochemical staining of bone marrow and peripheral blood cytospins is a sensitive and simple way to detect and quantitate breast cancer cells in hematopoietic specimens harvested for autotransplantation and that CD34-positive progenitor cell selection results in significant reduction in the number of breast cancer cells reinfused with marrow or peripheral blood stem cells.

Detection of Hematopoietic Stem Cells from Draining Lymph Node in Patients with Oral Cancer

Isolation and characterization of living circulating tumor cells in patients by immunomagnetic negative enrichment coupled with flow cytometry.

Immunohistochemical Analysis of Characteristic Phenotype of Dendritic Cell in Draining Lymph Node of Patients with Oral Squamous Cell Carcinoma

Investigation on related factors of CD 34+ cells in peripheral blood mobilization effect by G-SCF stimulation

The Hematopoietic Stem Cell Antigen, CD34, is Not Expressed on the Malignant Cells in Multiple Myeloma

Detection of T Lymphocyte Subset and NK Cell in Peripheral Blood of Patients with Colorectal Cancer

The Clinical Significance of the CD44v6 Expression in Peripheral Blood Mononuclear Cell and Cancerous Tissue of Patients with Gastric Cancer

[Isolation and in Vitro Characterization of CD133(+) Side Population Cells from Laryngeal Cancer Cell Line].

Quantitative Analyses of CD133 Expression Facilitate Researches on Tumor Stem Cells.

Evaluating Effect of CD34 Positive Selection with the Graft Cell-Model

Functional Detection of Dendritic Cells Induced from Human Umbilical Cord Blood CD34+ Cells in Vitro. Zhonghua Er Ke Za Zhi.

[In Vitro Identification and Characteristics of CD34- Leukemia Stem Cell in T(8;21) Acute Myeloid Leukemia].

Detection of CD44+CD24-/low in breast cancer stem cells and clinical significance

Genetic detection of lymph node micrometastases in colorectal cancer

Immunocytochemical detection of breast cancer cells in marrow and peripheral blood of patients undergoing high dose chemotherapy with autologous stem cell support

Using Detection of Survivin‐expressing Circulating Tumor Cells in Peripheral Blood to Predict Tumor Recurrence Following Curative Resection of Gastric Cancer

Validation of Gene Profiles for Analysis of Regional Lymphatic Metastases in Head and Neck Squamous Cell Carcinoma

Detection of cervical lymph node metastasis with cytokeratin immunohistochemical staining

CD44 as a molecular marker to screen tumor stem cells in hypopharyngeal carcinoma

Detection of T Cell Subsets in Peripheral Blood of Cervical Cancer and Its Clinical Significance

Detection of D2-40-positive lymphatic microvessel density and its clinical significance in lung cancer